Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04766788 · ClinicalTrials.gov registry record

Studying Students at Risk for COVID-19

A clinical trial, sponsored by University of Michigan.

Completed
Registry status
2,381
Enrollment target

NCT04766788: Completed study, sponsored by University of Michigan.

NCT04766788 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 2,381 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04766788 has completed, sponsored by University of Michigan.

COMPLETED
Registry status
2,381 participants
Enrollment target

Study Summary

The goal of this longitudinal observational study is to learn about how the COVID-19 has impacted and continues to impact students at the University of Michigan. We hope to determine whether a combination of (1) continuous heart rate obtained from wearable devices, (2) self-reported data from surveys and symptom logs, and (3) saliva samples can be used to help students self-monitor for infection and eventually be able to create a predictive model to detect illness early.

Primary Outcome

Feasibility will will be defined as wearing the Fitbit watch at least 8 hours per day up to at least 5 days of the week

Interventions

  • OTHER Wearable devices, saliva samples, survey measures

Trial Details

FieldValue
Enrollment Target 2,381 participants
Start Date 2020-09-03
Est. Completion 2023-04-18
University of Michigan

1,327 total trials

What the finished NCT04766788 record still lists

NCT04766788 is an observational study that tracks outcomes without assigning an intervention. Its 2,381 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Wearable devices, saliva samples, survey measures is the first listed.

NCT04766788 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04766788 about?

NCT04766788 is a clinical study titled "Studying Students at Risk for COVID-19". The goal of this longitudinal observational study is to learn about how the COVID-19 has impacted and continues to impact students at the University of Michigan. We hope to determine whether a combination of (1) continuous heart rate obtained from wearable devices, (2) self-reported data from survey...

What is the current status of trial NCT04766788?

This trial is currently completed. The enrollment target is 2,381 participants. The study started on 2020-09-03. Estimated completion is 2023-04-18.

What interventions are being tested in trial NCT04766788?

The interventions under investigation include: Wearable devices, saliva samples, survey measures (OTHER).

Who is sponsoring clinical trial NCT04766788?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05868421 · 2,376 participants · NA

    Veteran Social Support for Enhancing Use of Smoking Cessation Treatment

  • NCT06747494 · 2,396 participants · NA

    General vs Spinal in Total Joint Arthroplasty (TJA)

  • NCT05185440 · 2,400 participants · NA

    Reducing Alcohol Involved Sexual Violence in Higher Education

  • NCT05285527 · 2,400 participants · NA

    MiSight 1 Day Safety Post-Approval Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04766788, the US trial registry maintained by the National Library of Medicine. NCT04766788 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.